AzTrials
AzTrials

Kidney Failure, ChronicNCT02874521

Low-frequency Electrical Muscle Stimulation vs Cycle Training During Haemodialysis

A study testing Intra-dialytic LF-EMS and Intra-dialytic cycle training in people with Kidney Failure, Chronic, run by University Hospitals Coventry and Warwickshire NHS Trust at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the trial is to compare the effects of intra-dialytic low-frequency electrical muscle stimulation and intra-dialytic cycling, with usual care haemodialysis without exercise training. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Kidney Failure, Chronic
What is being tested?
Intra-dialytic LF-EMS and Intra-dialytic cycle training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
63 participants
Where
1 siteUnited Kingdom
Study dates
Mar 2014to Sep 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • On haemodialysis for at least 3months
  • On 3 times 4 hours of dialysis per week
  • Urea reduction rate of at least 65% during the three months before enrolment
  • Age 18 years or older
  • Able to complete the exercise test and exercise training
  • Able to provide informed consent
  • Life expectancy of more than 6 months according to clinical assessment

Who cannot join

  • Clinically significant valvular insufficiency
  • Clinically significant dysrythmia
  • Uncontrolled blood pressure: systolic > 160, diastolic >95 during the months before enrolment
  • Excessive fluid accumulation between dialysis sessions (>3 liters), more than twice pulmonary edema over 3 months before enrolment deemed to be due to excess fluid intake
  • Haemoglobin unstable and below 9.0
  • Ischemic cardiac event or intervention in the last 3 months
Show all 9Show fewer
  • Clinically significant, still active inflammatory or malignant process
  • Pacemaker or cardiac device (contraindicated for bioelectrical impedance)
  • Planned kidney transplant during study period.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University Hospital

    Coventry, CV2 2DX

Other trials in United Kingdom

About this study

Official title: Effects of Intra-dialytic Low-frequency Electrical Muscle Stimulation and Cycle Training on Cardiorespiratory Function and Muscular Strength: a Pilot Randomized Controlled Trial

The purpose of the trial is to compare the effects of intra-dialytic low-frequency electrical muscle stimulation and intra-dialytic cycling, with usual care haemodialysis without exercise training.

Read the detailed description

End stage renal disease is associated with reduced functional capacity. Dynamic exercise training i.e. cycling, performed between dialysis sessions or during dialysis (intra-dialytic) can be effective in improving functional capacity and quality of life. However, many patients are unable to engage in intra-dialytic cycling due to limiting comorbidities. Other exercise modalities should be considered. Low-frequency electrical muscle stimulation of the quadriceps is well tolerated and may improve functional capacity in clinical populations.

The trial is a longitudinal, randomised controlled trial. Participants will be randomly allocated to 10 weeks of 1) intra-dialytic low-frequency electrical muscle stimulation, 2) intra-dialytic cycling, or 3) usual care haemodialysis without exercise training. Outcomes will be assessed at baseline and 10 weeks by assessors blinded to group allocation.

Being tested
Intra-dialytic LF-EMS, Intra-dialytic cycle training
Medical subject headings
Kidney Failure, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intra-dialytic LF-EMSOther

    Also called Electrical muscle stimulation

    Electrical muscle stimulation during haemodialysis

  • Intra-dialytic cycle trainingOther

    Cycle training during haemodialysis

Study groups in NCT02874521
Study groupRoleWhat they receive
Intra-dialytic LF-EMSExperimentalPerformed twice weekly whilst seated on a standard dialysis chair. Delivered by adhesive electrodes in a neoprene garment, applied bilaterally to the quadriceps and hamstrings. Cardiovascular stimulus via rapid, rhythmical, sub-tetanic contractions. Short bursts of four pulses repeatedly delivered by stimulator at a frequency of 4Hz. Current amplitude adjustable from 40 - 200 mA with inbuilt controller. Conducted for one hour at the maximum tolerable intensity. Five minute warm-up and cool down at a lower frequency (3 Hz).
Receives: Other: Intra-dialytic LF-EMS
Intra-dialytic cycle trainingExperimentalSemi-recumbent cycling performed twice weekly whilst seated on a standard dialysis chair. Performed for up to one hour per session, initially at a workload (Watts) equivalent to that achieved at 40-60% VO2 reserve during cardiopulmonary exercise test. Exercise intensity regulated using a combination of heart rate and rating of perceived exertion (12-14). Workload adjusted weekly and controlled with a combination of pedal resistance and cadence to provide a personalised exercise prescription. Five minute warm-up and cool down each session.
Receives: Other: Intra-dialytic cycle training
Usual careNo interventionContinuation of dialysis treatment without the addition of an intra-dialytic exercise intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak oxygen uptake (VO2peak)

    Cardiopulmonary exercise test

    Measured: Baseline, 10 weeks

Secondary outcomes (4)
  1. Muscular strength

    Hand held dynamometer - quadriceps strength

    Measured: Baseline, 10 weeks

  2. Arterial remodelling

    Tonometry - pulse wave velocity

    Measured: Baseline, 10 weeks

  3. Cardiac remodelling

    Echocardiography - left ventricular volumes

    Measured: Baseline, 10 weeks

  4. Health related quality of life

    Questionnaire - KDQOL-36

    Measured: Baseline, 10 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Aug 2016 (estimated)
  2. Study startMar 2014
  3. Primary completionSep 2015
  4. Study completionSep 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
63 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02874521
Sponsor's protocol ID
GM118313
Status last verified
Aug 2016
First submitted
17 Aug 2016
Last updated
22 Aug 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • 2021 exceptional surveillance of chronic kidney disease (NICE guideline NG203) [Internet]. London: National Institute for Health and Care Excellence (NICE); 2021 Aug 25. No abstract available. Available from http://www.ncbi.nlm.nih.gov/books/NBK576880/

    PubMed 35077091
  • Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011 Oct 5;2011(10):CD003236. doi: 10.1002/14651858.CD003236.pub2.

    PubMed 21975737
  • Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2015 Sep;6(3):197-207. doi: 10.1002/jcsm.12043. Epub 2015 Jun 3.

    PubMed 26401465
  • Koufaki P, Mercer TH, Naish PF. Effects of exercise training on aerobic and functional capacity of end-stage renal disease patients. Clin Physiol Funct Imaging. 2002 Mar;22(2):115-24. doi: 10.1046/j.1365-2281.2002.00405.x.

    PubMed 12005153
  • Cheema B, Abas H, Smith B, O'Sullivan A, Chan M, Patwardhan A, Kelly J, Gillin A, Pang G, Lloyd B, Fiatarone Singh M. Randomized controlled trial of intradialytic resistance training to target muscle wasting in ESRD: the Progressive Exercise for Anabolism in Kidney Disease (PEAK) study. Am J Kidney Dis. 2007 Oct;50(4):574-84. doi: 10.1053/j.ajkd.2007.07.005.

    PubMed 17900457
  • Smart NA, Dieberg G, Giallauria F. Functional electrical stimulation for chronic heart failure: a meta-analysis. Int J Cardiol. 2013 Jul 15;167(1):80-6. doi: 10.1016/j.ijcard.2011.12.019. Epub 2012 Jan 10.

    PubMed 22236510
  • Bernier-Jean A, Beruni NA, Bondonno NP, Williams G, Teixeira-Pinto A, Craig JC, Wong G. Exercise training for adults undergoing maintenance dialysis. Cochrane Database Syst Rev. 2022 Jan 12;1(1):CD014653. doi: 10.1002/14651858.CD014653.

    PubMed 35018639

Questions about this trial

What is this clinical trial studying?

A study testing Intra-dialytic LF-EMS and Intra-dialytic cycle training in people with Kidney Failure, Chronic, run by University Hospitals Coventry and Warwickshire NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak oxygen uptake (VO2peak) (time frame: Baseline, 10 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02874521, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in